WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders
A

State of Biomarker in Fibrotic ILD: When Will They be Ready for Prime-Time?

By WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders FEATURING Antje Prasse
By WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders FEATURING Antje Prasse
131 views
July 22, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

17:07
Genentech & Novartis

Expert Perspectives on CSU

Feat. T. Murphy

Featured Video

18:08
Genentech & Novartis

Shared Voices in the CSU Community

Feat. S. Gawchik

Related Videos

51:53

ATS 2022: Approach to Lung Nodules in 2022

Shaheen Islam

12.9K views
15:31

Rapid Fire Journal Club 6 – SARCORT Trial (ERJ, 2023)

PulmPEEPs

D. Furfaro, L. Hedrick

20 views
16:13

Post COVID-19 Lung Complications

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

M. Padilla

8.9K views
53:31

Approaching Sarcoidosis Therapy From a 21st Century Perspective

CHEST 2022 Coverage

D. Culver

7.0K views
19:21

A Radiologist's Approach to Subsolid Pulmonary Nodules

CHEST 2022 Coverage

A. Guttentag

5.3K views
28:18

Advances and Updates in Sarcoidosis: Diagnosis and Treatment of Pulm…

UCLA Health

J. Belperio

4.5K views
52:53

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

4.4K views
24:02

Bronchoscopic Imaging for Interstitial Lung Disease

CHEST 2022 Coverage

G. Zhi Cheng

5.0K views
21:34

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

CHEST 2022 Coverage

T. Kulkarni

5.0K views
25:48

Sarcoidosis: Diagnosis and Management

University of Colorado Department of Medicine

N. Held

3.8K views
40:52

Interstitial Lung Disease in RA: RA-ILD Subtypes, Mortality Risk, RA…

RheumNow

J. Sparks, J. Cush

187 views
09:19

Rituximab versus Cyclophosphamide for the Treatment of Connective Ti…

Toby Maher

3.3K views
08:43

Review of Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-D…

Paolo Tarantino

46 views
33:57

Management of Pulmonary Fibrosis in Clinical Practice

National Jewish Health

J. Solomon

2.7K views
20:49

Progressive ILD on Rheumatic Diseases - The Rheumatologists' Perspec…

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

A. Hoffmann-Vold

101 views
18:52

Defining the Molecular Natural History of Early and Progressive Pulm…

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

N. Banovich

50 views
46:24

Interstitial Lung Disease: Multidisciplinary Discussion

UCLA Health

S. Sam Weigt, E. R. Volkmann, F. Abtin, M. Fishbein

3.5K views
19:32

EADV 2024 Insights: Eosinophilic Fasciitis

EADV 2024 Insights

F. Rongioletti

208 views
16:51

Challenges in ILD: Prediction With or Without Big Data

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

T. Fingerlin

105 views
27:38

Current and Evolving Paradigm of Anti-Inflammatory Therapy in Pulmon…

Temple Lung Center

R. Gupta

658 views
AUTOPLAY